N@N

SJI, AIRM, NKTR, MTD, AGO, BRS Expected To Be Up After Next Earnings Releases

^{Published on 2016-11-02 00:45:39 - WOPRAI}
 

November 2, 2016 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released Thursday, November 3rd 2016 and determining how the stocks have performed After their last 12 quarterly, 6 quarterly and earnings reports. South Jersey Industries Inc. (NYSE:SJI), Air Methods Corporation (NASDAQ:AIRM), Nektar Therapeutics (NASDAQ:NKTR), Mettler Toledo International Inc. (NYSE:MTD), Assured Guaranty Ltd. (NYSE:AGO), Bristow Group Inc. (NYSE:BRS) are all expected to be Up After their earnings are released Thursday. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go Up After earnings are released Thursday:

  Symbol  Company                          # of Reports         Quarter  Release Time
  SJI     South Jersey Industries Inc.     November Earnings    Q3       After
  AIRM    Air Methods Corporation          November Earnings    Q3       After
  NKTR    Nektar Therapeutics              November Earnings    Q3       After
  MTD     Mettler Toledo International Inc.  November Earnings    Q3       After
  AGO     Assured Guaranty Ltd.            November Earnings    Q3       After
  BRS     Bristow Group Inc.               November Earnings    Q2       After

South Jersey Industries Inc. (NYSE:SJI) - South Jersey Industries, Inc., through its subsidiaries, provides energy-related products and services. It engages in the purchase, transmission, and sale of natural gas. The company also sells natural gas and pipeline transportation capacity on a wholesale basis to residential, commercial, and industrial customers on the interstate pipeline system, as well as transports natural gas purchased directly from producers or suppliers to their customers. As of December 31, 2015, it had approximately 122.7 miles of mains in the transmission system and 6,503 miles of mains in the distribution system; and served 373,100 residential, commercial, and industrial customers in southern New Jersey. In addition, the company develops, owns, and operates energy projects, such as thermal facilities, combined heat and power facilities, landfill gas-fired electric production facilities, and solar projects that provide cooling, heating, and emergency power. Further, it markets natural gas storage, commodity, and transportation assets on a wholesale basis for energy marketers, electric and gas utilities, power plants, and natural gas producers in the mid-Atlantic, Appalachian, and southern regions of the United States. Additionally, the company acquires and markets natural gas and electricity to retail end users, as well as markets total energy management services; owns oil, gas, and mineral rights in the Marcellus Shale region of Pennsylvania; and services residential and small commercial HVAC systems, and installs small commercial HVAC systems, as well as provides plumbing services and services appliances. South Jersey Industries, Inc. was founded in 1910 and is based in Folsom, New Jersey..

Air Methods Corporation (NASDAQ:AIRM) - Air Methods Corporation, together with its subsidiaries, provides air medical emergency transport services and systems in the United States. The company operates in the Air Medical Services (AMS), Tourism, and United Rotorcraft (UR) segments. The AMS segment provides air medical transportation services to the general population as an independent service, as well as to hospitals and other institutions under exclusive operating agreements. Its services include medical care, aircraft operation and maintenance, dispatch and communications, and medical billing and collections. As of December 31, 2015, this segment s aircraft fleet consisted of 321 company-owned aircraft and 92 leased aircraft, as well as 54 aircraft owned by AMS customers and operated by the company under contracts with them. The Tourism segment provides aerial tours and charter flights, primarily focusing on Grand Canyon and Hawaiian Island tours. This segment markets its tours through Websites, as well as through various agencies, such as online booking companies, hotels, resorts, and cruise operators. It operates 65 helicopters and 2 fixed wing aircraft under three Part 135 Air Carrier Certificates. The UR segment designs, manufactures, installs, and certifies aircraft modular medical interiors, multi-mission interiors, and other aerospace and medical transport products for domestic and international customers. This segment also offers quality assurance and certification services. Air Methods Corporation was founded in 1982 and is headquartered in Englewood, Colorado..

Nektar Therapeutics (NASDAQ:NKTR) - Nektar Therapeutics develops drug candidates that utilize its PEGylation and polymer conjugate technology platforms in the United States. Its product pipeline includes drug candidates in therapeutic areas comprising oncology, pain, anti-infectives, and immunology. The company offers MOVANTIK, an oral peripherally-acting mu-opioid antagonist for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain, as well as MOVENTIG for the treatment of opioid-induced constipation in adult patients who have an inadequate response to laxatives. Its drug candidates in clinical development stage comprises ADYNOVATE that is in Phase III clinical trial for treating Hemophilia A; BAY41-6551, which is in Phase III clinical trial to treat gram-negative pneumonias; NKTR-181 that is in Phase III clinical trial for chronic pain; and NKTR-214 that is in Phase 1/2 stage to treat oncology, as well as MOVANTIK, which is in research/preclinical stage for treating chronic pain without constipation. The company s drug candidates in clinical development stage also include NKTR-102, a topoisomerase I inhibitor that is in Phase III clinical trial for metastatic breast cancer, as well as completed Phase II clinical trial stage for refractory ovarian cancer and second-line metastatic colorectal cancer; and in combination with 5-fluorouracil/leucovorin to treat gastrointestinal-related solid tumors, which has completed Phase I clinical trial. In addition, it holds license, manufacturing, and supply agreements with Ophthotech Corporation for Fovista; Halozyme Therapeutics, Inc. for PEG-PH20; and UCB Pharma for dapirolizumab pegol. Further, the company holds a range of license, manufacturing, and supply agreements with other biotechnology and pharmaceutical companies, including Amgen Inc.; Allergan, Inc.; Merck & Co., Inc.; Pfizer, Inc.; and F. Hoffmann-La Roche Ltd (Roche). Nektar Therapeutics was founded in 1990 and is headquartered in San Francisco, California..

Mettler Toledo International Inc. (NYSE:MTD) - Mettler-Toledo International Inc. manufactures and supplies precision instruments and services worldwide. The company operates in five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. It offers weighing instruments for laboratory, industrial, packaging, logistics, and food retailing applications; analytical instruments for use in life science; reaction engineering and real-time analytic systems used in drug and chemical compound development; process analytics instruments used for in-line measurement in production processes; and end-of-line inspection systems used in production and packaging for food, pharmaceutical, and other industries. Its laboratory instruments include laboratory balances, liquid pipetting solutions, titrators, physical value analyzers, and thermal analysis systems, as well as other analytical instruments, such as moisture analyzers and density refractometers; and LabX, a PC-based laboratory embedded software platform. The company s industrial solutions comprise industrial weighing instruments and terminals, automatic identification and data capture solutions, vehicle scale systems, industrial software, and product inspection systems. Its retail weighing solutions consist of multiple weighing and food labeling solutions, stand-alone scales, and networked scales and software for handling fresh goods, such as meats, vegetables, fruits, and cheeses. The company serves the life science industry covering pharmaceutical and biotechnology companies, and independent research organizations; food and beverage producers; food retailers; chemical, specialty chemical, and cosmetics companies; transportation and logistics, metals, and electronics industries; and the academic community. The company markets its products through its direct sales force and indirect distribution channels. Mettler-Toledo International Inc. was founded in 1991 and is based in Columbus, Ohio..

Assured Guaranty Ltd. (NYSE:AGO) - Assured Guaranty Ltd., through its subsidiaries, provides credit protection products to public finance, infrastructure, and structured finance markets in the United States and internationally. It offers financial guaranty insurance that protects holders of debt instruments and other monetary obligations from defaults in scheduled payments. The company insures various debt obligations, including bonds issued by the United States state or municipal governmental authorities; and notes issued to finance infrastructure projects. It also insures and reinsures various types of the United States public finance obligations, such as general obligation, tax-backed, municipal utility, transportation, healthcare, higher education, housing revenue, infrastructure, investor-owned utility, and other public finance bonds; and various types of non-United States public finance obligations comprising infrastructure finance, regulated utilities, pooled infrastructure, and other public finance obligations. In addition, the company insures and reinsures various types of the United States and non-United States structured finance obligations, including pooled corporate obligations, residential mortgage-backed securities, financial products, consumer receivables securities, commercial mortgage-backed securities, commercial receivables securities, insurance securitization obligations, and other structured finance securities. Assured Guaranty Ltd. markets its financial guaranty insurance directly to issuers and underwriters of public finance and structured finance securities, as well as to investors in such obligations. The company was founded in 2003 and is based in Hamilton, Bermuda..

Bristow Group Inc. (NYSE:BRS) - Bristow Group Inc. provides industrial aviation services to the offshore energy industry in Africa, the Americas, the Asia Pacific, and Europe Caspian. Its helicopters are used principally to transport personnel between onshore bases and offshore production platforms, drilling rigs, and other installations, as well as to transport time-sensitive equipment to these offshore locations. The company also offers helicopter flight training services to commercial pilots and flight instructors, as well as military training services through its Bristow Academy. In addition, it provides helicopter repair and maintenance services; and search and rescue services to oil and gas companies. The company provides its helicopter services to integrated, national, and independent oil and gas companies. As of March 31, 2016, it operated a fleet of 463 aircraft. The company was formerly known as Offshore Logistics Inc. and changed its name to Bristow Group Inc. in February 2006. Bristow Group Inc. was founded in 1955 and is headquartered in Houston, Texas..

About BUYINS.NET

BUYINS.NET, http://www.buyins.net, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS Friction Factor - Market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements" Naked Shorts (RegSho) - Tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING Earnings - Predicts probability, price move and length of move before and after all US stock earnings reports Seasonality - Predicts probability, price move and length of move based on exact time of year for all US stocks Group Correlation - Tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups SqueezeTrigger - Massive database that tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock. Valuation - Tracks all known valuation models and applies them. GATS - Tracks and quantifies known trading strategies by backtesting, optimizing and running genetic algorithms and neural networks to ascertain best trading strategies. PatternScan - Automates tracking of every technical pattern and predicts next move in stocks. Insider - Tracks insiders trading records and determines trading performance. Trades by higher-level insiders are generally more predictive than trades by lower level insiders Events - Tracks patterns directly correlated to specific events.

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. [symbol] has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net